Littérature scientifique sur le sujet « PLUMBAGO ZEYLANICA »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « PLUMBAGO ZEYLANICA ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "PLUMBAGO ZEYLANICA"
Aleem, Mohd. « Anti-Inflammatory and Anti-Microbial Potential of Plumbago zeylanica L. : A Review ». Journal of Drug Delivery and Therapeutics 10, no 5-s (15 octobre 2020) : 229–35. http://dx.doi.org/10.22270/jddt.v10i5-s.4445.
Texte intégralPhuong, Nguyen Tran Dong, et Tran Thi Xuan Huong. « Effect of natural auxin from portulaca grandiflora hook and Ipomoea batatas (L.) Poir on the formation adventitious roots in vitro of Plumbago zeylanica L. » ENGINEERING AND TECHNOLOGY 8, no 2 (4 juin 2020) : 30–37. http://dx.doi.org/10.46223/hcmcoujs.tech.en.8.2.344.2018.
Texte intégralPurwoko, Mitayani, Harijono Kario Sentono, Bambang Purwanto et Dono Indarto. « Phytochemical evaluation of Plumbago zeylanica roots from Indonesia and assessment of its plumbagin concentration ». Folia Medica 64, no 1 (28 février 2022) : 96–102. http://dx.doi.org/10.3897/folmed.64.e58086.
Texte intégralChelladurai, Iyyanar, et Habeebmoon K C. « Comparative HPTLC fingerprint profile of three types of Kodiveli used in Siddha ». International Journal of Ayurvedic Medicine 13, no 1 (5 avril 2022) : 87–95. http://dx.doi.org/10.47552/ijam.v13i1.2336.
Texte intégralMing, Yong, Jing Wang, Jin Yang et Wei Liu. « Chemical Constituents of Plumbago Zeylanica L. » Advanced Materials Research 308-310 (août 2011) : 1662–64. http://dx.doi.org/10.4028/www.scientific.net/amr.308-310.1662.
Texte intégralFerreira, G. M., et K. S. Laddha. « A METHOD FOR PREPARATION OF DROSERONE FROM PLUMBAGIN ». INDIAN DRUGS 50, no 05 (28 mai 2013) : 53–56. http://dx.doi.org/10.53879/id.50.05.p0053.
Texte intégralFerreira, G. M., et K. S. Laddha. « A METHOD FOR PREPARATION OF DROSERONE FROM PLUMBAGIN ». INDIAN DRUGS 50, no 05 (28 mai 2013) : 53–56. http://dx.doi.org/10.53879/id.50.05.p0053.
Texte intégralAdusei, Emmanuel B. A., Reimmel K. Adosraku, James Oppong-Kyekyeku et Cedric D. K. Amengor. « Investigation of Acid-Base Indicator Property of Plumbagin from Plumbago zeylanica Linn ». International Journal of Analytical Chemistry 2019 (18 août 2019) : 1–13. http://dx.doi.org/10.1155/2019/4061927.
Texte intégralPatel, Hetal D., Ramar Krishnamurthy et Musibau A. Azeez. « Effect of Biofertilizer on Growth, Yield and Bioactive Component of Plumbago zeylanica (Lead Wort) ». Journal of Agricultural Science 8, no 5 (13 avril 2016) : 141. http://dx.doi.org/10.5539/jas.v8n5p141.
Texte intégralTan, Ming Xiong, Xu Jian Luo, Yun Qiong Gu et Gong Cong Lu. « The Interaction of Cytotoxic Sm (III) Complex of Plumbagin with Bovine Serum Albumin ». Advanced Materials Research 634-638 (janvier 2013) : 1380–83. http://dx.doi.org/10.4028/www.scientific.net/amr.634-638.1380.
Texte intégralThèses sur le sujet "PLUMBAGO ZEYLANICA"
Nguyen, Anh Tho. « Structure elucidation and biological evaluation of cytotoxic constituents isolated from three Vietnamese medicinal plants :Plumbago Zeylanica, Scrophularia Ningpoensis and Disporopsis Aspera ». Doctoral thesis, Universite Libre de Bruxelles, 2005. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/210998.
Texte intégralROY, ARPITA. « BIOTECHNOLOGICAL APPROACHES FOR THE PRODUCTION OF PLUMBAGIN FROM PLUMBAGO ZEYLANICA ». Thesis, 2020. http://dspace.dtu.ac.in:8080/jspui/handle/repository/18075.
Texte intégralHsieh, Yen-Ju, et 謝硯如. « Herbal analysis of plumbagin content in Plumbago zeylanica L. and its pharmacokinetics in rats ». Thesis, 2009. http://ndltd.ncl.edu.tw/handle/67603226326872277118.
Texte intégral國立陽明大學
傳統醫藥學研究所
97
Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) is an herbal ingredient which is isolated from the root of Plumbago zeylanica L. In previous reports, there is information on the separations of plumbagin from P. zeylanica L. and its analytical method. Also in recent years, some studies investigated pharmacological functions such as anti-cancer, anti-inflammation and central nervous system effects. However, the absorption, distribution, metabolism, and elimination of plumbagin are still unknown. First of all, a reliable liquid chromatography coupled with tandem mass spectrometric (LC-MS/MS) method was developed to determine the contents of plumbagin from P. zeylanica L. Secondly, an automated blood sampling system for serial blood sampling from conscious and freely moving rats coupled with LC-MS/MS method was used to evaluate the oral bioavailability of plumbagin. Thirdly, microdialysis sampling techniques coupled with high performance liquid chromatography and ultraviolet spectrometry was developed to simultaneously assess the unbound plumbagin in rat blood and bile. Moreover, the roles of P-glycoprotein transport and glucuronidation metabolism on the pharmacokinetics of plumbagin were also estimated by using cyclopsorin A and probenecid to inhibit respective pathways. Finally, the elimination of plumbagin in urine and feces were measured to determine the unabsorbed part and possible metabolites of plumbagin after oral administration. The results indicate that mass fractions of plumbagin in Plumbago zeylanica L. for H2O, 50 % ethanol (v/v) and 95 % ethanol (v/v) were 0.2 ± 0.04, 3.9 ± 0.71 and 13.4 ± 1.30 g/kg, respectively. The oral bioavailability of plumbagin was 38.7 ± 5 %. Unbound plumbagin appeared in blood and bile microdialysate. The AUC of plumbagin in blood and bile were 59.9 ± 7.1 and 31.2 ± 1.8 min・µg/mL, respectively. Furthermore, the bile-to-blood distribution ratio (AUCbile/AUCblood) of plumbagin was 1.7. These results suggest that plumbagin can be excreted in the bile. In combination with P-glycoprotein inhibitor, the concentration of plumbagin in bile declined, but not in blood. This data supports the idea that excretion of plumbagin in bile is regulated by P-glycoprotein. In combination with glucuronidation inhibitor, the concentration of plumbagin in bile increased, but not in blood. The result supports that plumbagin excreted through the glucuronidation pathway. 49.2 % of plumbagin appeared in feces within 84 hours, and 12 % of plumbagin appeared in urine 120 hours after oral administration, approximately. Furthermore, possible metabolites of plumbagin were found in rat urine and they were produced by the metabolism of plumbagin in liver with phase I aliphatic hydroxylation (MW 203) and phase II glucuronidation (MW 363 and 539) in urine, as identified by LC-MS/MS. In conclusion, this study developed a reliable LC-MS/MS to determine the absorption, distribution, metabolism and elimination of plumbagin in the rat. Herbal analysis of Plumbago zeylanica L. and pharmacokinetics of plumbagin will provide some valuable information for future clinical application.
THAKRAN, NEERU. « ESTIMATION OF PLUMBAGIN BY RP-HPLC & ; FAME ANALYSIS BY GC-MS OF IMPORTANT MEDICINAL PLANT PLUMBAGO ZEYLANICA ». Thesis, 2016. http://dspace.dtu.ac.in:8080/jspui/handle/repository/15047.
Texte intégralRASTOGI, ANSHIKA. « BIOTIC ELICITORS USED TO ENHANCE PLUMBAGIN PRODUCTION IN PLUMBAGO ZEYLANICA AND ASSESMENT OF ANTIOXIDANT AND ANTIBACTERIAL ACTIVITY ». Thesis, 2020. http://dspace.dtu.ac.in:8080/jspui/handle/repository/18363.
Texte intégralHuang, Tung-Liang, et 黃棟樑. « Studies of anti-Helicobacter pylori activity of Plumbago zeylanica Linn., a Taiwanese folk medicinal plant ». Thesis, 2004. http://ndltd.ncl.edu.tw/handle/39249470664857591359.
Texte intégral國立中興大學
食品科學系
92
Helicobacter pylori has been verified to be strongly correlated to gastric cancer and peptic ulceration. The most effective and famous treatment for H. pylori is a triple therapy, which combines two antibiotics with either an acid suppressor or a stomach lining protector. However, resistance to some antibiotics became a problem due to the frequently use of antibiotics. In this study, first, ethanol extracts of fifty Taiwanese folk medicinal plants were screened for their anti-H. pylori activity. Five herbs, Plumbago zeylanica Linn. (PZL), Paederia scandens Mer, Anisomeles indica (L.) O. Kuntze, Alpinia speciosa (Wendl.) K. Schum. and Bombax malabaricum DC., showed strong anti-H. pylori activity. Twenty six herbs including Artemisia argvi Levl. et Vant, Bidens bipinnata L., Bletilla formosana (Hayata) Schltr, Chenopodium ambrosioides L., Canarium album (Lour.) Raeuschel, Centella asiatica (L.) Urban., Ehretia acuminata R. Br., Houttuynia cordata Thunb., Litsea cubeba (Lour.) Persoon, Ludwigia octovalvis (Jacq.) Raven., Melastoma candidum D. Don, Polygonum chinense Linn., Psidium guajava L., Phyla nodiflora (Linn.) Greene, Polygonum senticosum (Meissn) Franch. et Sav., Rhus semialata Merr. var. roxburghiana DC, Sonchus arvensis Linn., Sphenomeris chusana (L.) Copel, Sambucus chinensis Lindl., Setaria palmfolia Stapf, Senecio scandens Buch-Ham., Tridax procumbens L. , Vernonia cinerea (L.) Less., Wikstroemia indica (L.) C. A. Mey, Xanthium strumarium Linn., and Zanthoxylum nitidum (Roxb.) DC. showed moderate anti-H. pylori activity. The other nineteen herbs including Areca catechu Linn., Agrimonia pilosa Ledeb., Amaranthus spinosus L., Amaranthus virdis L., Bischofia javanica Blume, Bidens pilosa L. var. minor (Blume) Sherff, Cayratia japonica (Thunb.) Gagnep., Catharanthus roseus (L.) G. Don., Cycas revoluta Thunb., Euphorbia hirta Linn., Flemingia philippinensis Merr. & Rolfe, Gnaphalium adnatum Wall. ex DC., Hibiscus muthtabilis Linn., Milletia reticulata Bentham, Phyllanthus urinaria Linn., Sophora flavescens Ait., Solanum nigrum Linn., Sida rhombifolia Linn., and Viola mandshurica only showed low anti-H. pylori activity. PZL, which showed the strongest anti-H. pylori activity in the primary screening, was selected as study material , and the anti-H. pylori activities of PZL extracts were discussed in this study. PZL is a plant that grows throughout Asia and Africa. The whole plant and its roots have been used as a folk medicine for the treatment of rheumatic pain, dysmenorrhea, carbuncle, coutusion of extremities, ulcers, and killing intestinal parasites in Taiwan. To test the anti-H. pylori activity of PZL, four kinds of extracts were prepared to test on five H. pylori strains. Water and the organic solvents such as ethanol, acetone and ethyl acetate were used for PZL extraction. The ethyl acetate extract showed greatest anti-H. pylori activaty and lowest minimum inhibitory concentrations (MICs) (0.32 mg/mL ~ 1.28 mg/mL). Bactericidal activities were observed on the ethyl acetate, acetone and ethanol extracts studies. The ascending order of minimum bactericidal concentration (MBCs) was ethyl acetate, acetone, and ethanol extracts, and bactericidal activities were appeared to be dose dependent. The bactericidal activity observed on the ethyl acetate extract acted over a wide pH range (pH 2-7). The anti-H. pylori activity wouldn’t be affected by pH, even pretreating the ethyl acetate extract in pH 1-7 buffer for 2 hours wouldn’t affected its anti-H. pylori activity. According to the literatures, the major ingredient, plumbagin, derived from the roots of PLZ was a naphthoquinone compound. In this study, plumbagin also observed to have strong anti-H. pylori activity. A High-performance Liquid Chromatography (HPLC) assay was developed and validated for the quantitative analysis of plumbagin of PZL. The reverse-phase HPLC was performed by using a gradient mobile phase composing water and methanol, and peaks were detected at 254 nm (ultraviolet detection). Standard curves were linearized in the range from 10 to 200 g/mL (regression coefficient r2 = 0.99995). After spiked 50, 100, and 150 g/mL of plumbagin standard solution, the recoveries were between 97.45 % and 99.24 %. Both the intra-day and inter-day precision (RSD) were found less than 1 % coefficient variation at concentrations of 50, 100, and 150 g/mL. The detection and quantitation limits were 210-4 and 610-4 g, respectively. Based on the validation results, the analytical method showed to be a precise, accurate and stable method to quantify plumbagin of PZL.
Chen, Yi-Chun, et 陳怡君. « Regulation of Proliferation and Cytokine Genes Expression in Human Peripheral Blood Mononuclear Cells by Bioactive Components from Plumbago zeylanica ». Thesis, 2003. http://ndltd.ncl.edu.tw/handle/36227376478546430081.
Texte intégral國立陽明大學
藥理學研究所
91
Action mechanisms of elliptinone (C22H14O6; M.W. 374), xanthyletin (C14H12O3; M.W. 228), xanthoxyletin (C15H14O4; M.W. 258), seselin (C14H12O3; M.W. 228), 5-methoxyseselin (C15H14O4; M.W. 258), and suberosin (C15H16O3; M.W. 244) isolated from Plumbago zeylanica on phytohemagglutinin (PHA) stimulated cell proliferation were studied in primary culture of human peripheral blood mononuclear cells (PBMCs). The results demonstrated that these components suppressed PBMCs proliferation, at about 0 to 24 hr after stimulation with PHA. Cell cycle analysis indicated that elliptinone, xanthyletin, xanthoxyletin, seselin, 5-methoxyseselin, and suberosin arrested the cell cycle progression of activated PBMCs from the G1 transition to the S phase. To further localize the point in the cell cycle at which arrest occurred, a set of key regulatory events leading to the G1/S boundary, including the expression and production of cyclins and cytokines, activation of NF-AT and NF-κB, mobilization of intracellular Ca2+ ([Ca2+]i), and phosphorylation of mitogen-activated protein (MAP) kinases, were examined. These compounds suppressed, in activated PBMCs lymphocytes, the production and mRNA expression of interleukin-2 (IL-2) and interferon-γ (IFN-γ). The levels of Cyclin D3 and Cyclin E proteins in PBMCs stimulated with PHA were reduced by subersoin. Both 5-methoxyseselin and suberosin impaired the production of Cyclin A in activated PBMCs. Results of confocal microscopy analysis indicated that the translocation of the NF-AT and NF-κB in PBMCs induced by PHA were suppressed by 5-methoxyseselin and suberosin. Furthermore, 5-methoxyseselin and suberosin reduced [Ca2+]i in activated PBMCs. The phosphorylation of extracellular-signal regulated kinase (ERK) protein in activated PBMCs stimulated with PHA was attenuated by 5-methoxyseselin and suberosin. Thus, the suppressant effects of 5-methoxyseselin and suberosin on proliferation of PBMCs activated by PHA appeared to be mediated, at least in part, through reduction of [Ca2+]i , ERK kinases activation and early genes expression in PBMCs, especially those of important cyclins, IL-2, and IFN-γ, and arresting cell cycle progression in the cells.
Chapitres de livres sur le sujet "PLUMBAGO ZEYLANICA"
Dev, Sukh. « Plumbago zeylanica ». Dans Prime Ayurvedic Plant Drugs, 564–70. Cham : Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-22075-3_81.
Texte intégralKhare, C. P. « Plumbago zeylanica Linn. » Dans Indian Medicinal Plants, 1. New York, NY : Springer New York, 2007. http://dx.doi.org/10.1007/978-0-387-70638-2_1235.
Texte intégralAkbar, Shahid. « Plumbago zeylanica L. (Plumbaginaceae) ». Dans Handbook of 200 Medicinal Plants, 1475–83. Cham : Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-16807-0_152.
Texte intégralRussell, Scott D. « Biphasic pollen tube growth in Plumbago zeylanica ». Dans Biotechnology and Ecology of Pollen, 385–90. New York, NY : Springer New York, 1986. http://dx.doi.org/10.1007/978-1-4613-8622-3_62.
Texte intégralBloch, Khalida, Vijay Singh Parihar, Minna Kellomäki et Sougata Ghosh. « Natural Compounds from Plumbago zeylanica as Complementary and Alternative Medicine ». Dans Handbook of Oxidative Stress in Cancer : Therapeutic Aspects, 415–42. Singapore : Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-5422-0_33.
Texte intégralBloch, Khalida, Vijay Singh Parihar, Minna Kellomäki et Sougata Ghosh. « Natural Compounds from Plumbago zeylanica as Complementary and Alternative Medicine ». Dans Handbook of Oxidative Stress in Cancer : Therapeutic Aspects, 1–28. Singapore : Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-1247-3_33-1.
Texte intégral« Chitrak (Plumbago zeylanica) ». Dans Rasayana, 114–15. CRC Press, 2002. http://dx.doi.org/10.1201/b12602-41.
Texte intégralTripathi, M. K., G. Tiwari, Sushma Tiwari, Niraj Tripathi, Mohini Sharma, Shashank Bhargav, S. L. Patidar et Sharad Tiwari. « Influence of Plant Growth Regulators on In vitro Morphogenesis in Plumbago Zeylanica Linn. » Dans Research Aspects in Biological Science Vol. 7, 96–123. Book Publisher International (a part of SCIENCEDOMAIN International), 2022. http://dx.doi.org/10.9734/bpi/rabs/v7/3679a.
Texte intégral